Designs for experiments--parallel comparisons of treatment
- PMID: 6633587
- DOI: 10.1056/NEJM198311243092105
Designs for experiments--parallel comparisons of treatment
Abstract
Clinical trials of medical treatments often compare two treated groups or a treated group with a separate but concurrent control group. We have examined a consecutive series of 47 such parallel studies reported in the Journal in 1978-1979, including 35 with random assignment to the treated or control group, to discover how this approach is actually used. A major strength of these studies as a group was the frequent use of randomized treatment assignment. Common problems included lack of sufficient detail about methods of randomization, failure to provide enough detail about patient sources, and insufficient use of multivariate statistical techniques and of statistical modeling. We emphasize the importance of avoiding bias by balancing prognostic factors when assigning patients to treatments, reducing bias by modeling the influence of prognostic factors on response, and increasing precision by modeling. We also advocate the careful consideration of the relevance of a treatment comparison within the study to the external world of clinical practice.
Similar articles
-
Designing for cancer clinical trials: selection of prognostic factors.Cancer Treat Rep. 1980 Feb-Mar;64(2-3):499-502. Cancer Treat Rep. 1980. PMID: 7407790
-
Bias in treatment assignment in controlled clinical trials.N Engl J Med. 1983 Dec 1;309(22):1358-61. doi: 10.1056/NEJM198312013092204. N Engl J Med. 1983. PMID: 6633598 Clinical Trial.
-
Patient heterogeneity in clinical trials.Cancer Treat Rep. 1980 Feb-Mar;64(2-3):405-10. Cancer Treat Rep. 1980. PMID: 7407777
-
On design considerations and randomization-based inference for community intervention trials.Stat Med. 1996 Jun 15;15(11):1069-92. doi: 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.0.CO;2-Q. Stat Med. 1996. PMID: 8804140 Review.
-
[Treatment by drawing lots in a therapeutic trial with a balance distribution of prognostic factors: the minimization method].Rev Epidemiol Sante Publique. 1988;36(2):138-43. Rev Epidemiol Sante Publique. 1988. PMID: 3045921 Review. French.
Cited by
-
A tutorial on methods to estimating clinically and policy-meaningful measures of treatment effects in prospective observational studies: a review.Int J Biostat. 2011;7(1):6. doi: 10.2202/1557-4679.1285. Epub 2011 Jan 6. Int J Biostat. 2011. PMID: 22848188 Free PMC article. Review.
-
Grading clinical research: a midterm report card.Can Med Assoc J. 1984 Nov 1;131(9):1025-7. Can Med Assoc J. 1984. PMID: 6498714 Free PMC article. No abstract available.
-
Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials.J Med Ethics. 1998 Dec;24(6):401-8. doi: 10.1136/jme.24.6.401. J Med Ethics. 1998. PMID: 9873981 Free PMC article. Review.
-
Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.Support Care Cancer. 1993 Jul;1(4):186-94. doi: 10.1007/BF00366445. Support Care Cancer. 1993. PMID: 8193880 Clinical Trial.
-
Development of a rational practice of therapeutics.BMJ. 1990 Oct 3;301(6754):729-33. doi: 10.1136/bmj.301.6754.729. BMJ. 1990. PMID: 2224248 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical